- Previous Close
0.0340 - Open
0.0340 - Bid 0.0346 x --
- Ask 0.0427 x --
- Day's Range
0.0340 - 0.0340 - 52 Week Range
0.0240 - 0.2200 - Volume
4,000 - Avg. Volume
6,562 - Market Cap (intraday)
7.826M - Beta (5Y Monthly) 1.96
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Jun 30, 2025 - Jul 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with Benuvia Operations, LLC to produce cGMP pharmaceutical-grade CBD active pharmaceutical ingredients. PharmaCielo Ltd. is headquartered in Toronto, Canada.
www.pharmacielo.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PCLOF
View MorePerformance Overview: PCLOF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PCLOF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PCLOF
View MoreValuation Measures
Market Cap
7.64M
Enterprise Value
21.90M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.00
Price/Book (mrq)
--
Enterprise Value/Revenue
8.99
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-262.70%
Return on Assets (ttm)
-14.33%
Return on Equity (ttm)
--
Revenue (ttm)
3.48M
Net Income Avi to Common (ttm)
-9.14M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
147.94k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.45M